Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Valerie Arnold

Child & Adolescent Psychiatry Memphis, TN Medical Doctor

NPI 1851358618 CMS profile 38286

1910 Nonconnah Blvd, Suite 120, Memphis, TN 38132

Open in the dashboard

General payments

$43,054

77 records reported · program years 2019–2025

Research payments

$198,660

Paid to them · 37 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$3,433,994 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Valerie Arnold of Memphis, TN is reported in the CMS Open Payments database as having received $43,054 across 77 general payments and $198,660 in research payments paid to them. Separately, studies naming them as principal investigator received $3,433,994 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 99th percentile of Child & Adolescent Psychiatry profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,742 2
2024 General $1,490 12
2023 General $330 4
2022 General $3,906 9
2020 General $3,700 3
2020 Research $1,769 11
2019 General $31,887 47
2019 Research $196,891 26

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Valerie Arnold
  • Child & Adolescent Psychiatry median
  • Middle half of Child & Adolescent Psychiatry
  • National median

In program year 2025, general payments to Valerie Arnold were reported at $1,742. Among 1,601 Child & Adolescent Psychiatry profiles paid that year, the median was $132 and the middle half received between $41 and $474.

Show as a table
Year Valerie Arnold Child & Adolescent Psychiatry median Middle half National median
2019 $31,887 $129 $42–$419 $163
2020 $3,700 $81 $28–$226 $114
2021 $0 $115 $31–$326 $132
2022 $3,906 $124 $40–$382 $149
2023 $330 $130 $45–$420 $160
2024 $1,490 $141 $42–$490 $164
2025 $1,742 $132 $41–$474 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Ironshore Pharmaceuticals Inc. $26,226 37 payments
  2. Supernus Pharmaceuticals, Inc. $8,071 11 payments
  3. Boehringer Ingelheim International GmbH $3,613 4 payments
  4. Vertical Pharmaceuticals, LLC $1,600 1 payment
  5. Boehringer Ingelheim Pharmaceuticals, Inc. $1,575 11 payments
  6. Shire North American Group Inc $1,419 4 payments
  7. Biogen, Inc. $412 5 payments
  8. Tris Pharma Inc $122 3 payments
  9. Boston Scientific Corporation $17 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $19,345 11 payments
  2. Consulting Fee $12,413 6 payments
  3. Travel and Lodging $5,471 19 payments
  4. Food and Beverage $4,164 39 payments
  5. Honoraria $1,600 1 payment
  6. Education $62 1 payment
Products named General payments · program years 2019–2025
  1. Jornay PM 20mg capsules (Bottle of 100) $25,236 35 payments
  2. Relexxii $1,600 1 payment
  3. MYDAYIS $1,419 4 payments
  4. JORNAY PM $990 2 payments
  5. Quillivant $46 1 payment
  6. QELBREE $39 1 payment
  7. WaveWriter Alpha Prime 16 $17 1 payment
  8. Dyanavel XR $15 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Arbor Pharmaceuticals, Inc. $193,345 11 payments
  2. Otsuka Pharmaceutical Development & Commercialization, Inc. $2,820 12 payments
  3. ACADIA Pharmaceuticals Inc $1,489 4 payments
  4. Takeda Pharmaceuticals U.S.A., Inc. $1,007 10 payments

Records

114 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Child & Adolescent Psychiatry in Tennessee

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record